Imfinzi

This is the first and only perioperative immunotherapy approved to treat early gastric cancers

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually

In 2022, nearly one million new patients were diagnosed with gastric cancer

Approximately 6,600 people are diagnosed with liver cancer every year in the UK

Gastric cancer is the fifth leading cause of cancer-related deaths globally

More than 35,000 people in five major European countries were treated for the disease last year

More than 614,000 cases of bladder cancer are diagnosed globally every year

Around half of NMIBC patients are classed as being high-risk for disease progression or recurrence

More than 450,000 people are diagnosed with lung cancer every year in Europe

Around half of patients who undergo bladder removal surgery experience disease recurrence

The drug is already approved in the EU to treat extensive stages of the disease

Almost one million cases of the disease are diagnosed globally every year